Torthaí cuardaigh - Zhuo, Jianyong

The Gut-liver Axis in Immune Remodeling: New insight into Liver Diseases de réir Yang, Xinyu, Lu, Di, Zhuo, Jianyong, Lin, Zuyuan, Yang, Modan, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The ongoing trends of patient‐derived xenograft models in oncology de réir Zhuo, Jianyong, Su, Renyi, Tan, Winyen, Lian, Zhengxing, Lu, Di, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Laparoscopic management of enterohepatic migrated fish bone mimicking liver neoplasm: A case report and literature review de réir Chen, Jun, Wang, Chao, Zhuo, Jianyong, Wen, Xue, Ling, Qi, Liu, Zhikun, Guo, Haijun, Xu, Xiao, Zheng, Shusen

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

High Expression of Human AugminComplex Submit 3 Indicates Poor Prognosis and Associates with Tumor Progression in Hepatocellular Carcinoma de réir Zhang, Xuanyu, Zhuang, Runzhou, Ye, Qianwei, Zhuo, Jianyong, Chen, Kangchen, Lu, Di, Wei, Xuyong, Xie, Haiyang, Xu, Xiao, Zheng, Shusen

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1 de réir Ling, Sunbin, Xie, Haiyang, Yang, Fan, Shan, Qiaonan, Dai, Haojiang, Zhuo, Jianyong, Wei, Xuyong, Song, Penghong, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma de réir Wang, Jianguo, Zhuo, Jianyong, Tao, Yaoye, Xu, Shengjun, Chen, Zun, Yang, Fan, Ke, Qinghong, Xie, Haiyang, Zheng, Shusen, Wang, Hangxiang, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Molecular phenotypes reveal heterogeneous engraftments of patient-derived hepatocellular carcinoma xenografts de réir Zhuo, Jianyong, Lu, Di, Wang, Jianguo, Lian, Zhengxing, Zhang, Jiali, Li, Huihui, Cen, Beini, Wei, Xuyong, Wei, Qiang, Xie, Haiyang, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

CR6-interacting factor 1 inhibits invasiveness by suppressing TGF-β-mediated epithelial-mesenchymal transition in hepatocellular carcinoma de réir Zhuang, Runzhou, Lu, Di, Zhuo, Jianyong, Zhang, Xuanyu, Wang, Kun, Wei, Xuyong, Wei, Qiang, Wang, Wei, Xie, Haiyang, Zhou, Lin, Xu, Xiao, Zheng, Shusen

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma de réir Lu, Di, Yang, Fan, Zhuo, Jianyong, Yang, Modan, Lin, Zuyuan, Jin, Pingbo, Cai, Xuechun, Cen, Beini, Wang, Jianguo, Wei, Xuyong, Zheng, Shusen, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A Contrast-Enhanced Computed Tomography Based Radiomics Approach for Preoperative Differentiation of Pancreatic Cystic Neoplasm Subtypes: A Feasibility Study de réir Shen, Xiaoyong, Yang, Fan, Yang, Pengfei, Yang, Modan, Xu, Lei, Zhuo, Jianyong, Wang, Jianguo, Lu, Di, Liu, Zhikun, Zheng, Shu-sen, Niu, Tianye, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Single‐cell profiling reveals distinct immune phenotypes that contribute to ischaemia‐reperfusion injury after steatotic liver transplantation de réir Yang, Xinyu, Lu, Di, Wang, Rui, Lian, Zhengxing, Lin, Zuyuan, Zhuo, Jianyong, Chen, Hao, Yang, Modan, Tan, Winyen, Yang, Mengfan, Wei, Xuyong, Wei, Qiang, Zheng, Shusen, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy de réir Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Hepatocellular Carcinoma: Self‐Activated Cascade‐Responsive Sorafenib and USP22 shRNA Co‐Delivery System for Synergetic Hepatocellular Carcinoma Therapy (Adv. Sci. 5/2021) de réir Xu, Shengjun, Ling, Sunbin, Shan, Qiaonan, Ye, Qianwei, Zhan, Qifan, Jiang, Guangjiang, Zhuo, Jianyong, Pan, Binhua, Wen, Xue, Feng, Tingting, Lu, Haohao, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Xiang, Jiajia, Shen, Youqing, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib de réir Zhuo, Jianyong, Lu, Di, Lin, Zuyuan, Yang, Xinyu, Yang, Modan, Wang, Jianguo, Tao, Yaoye, Wen, Xue, Li, Huihui, Lian, Zhengxing, Cen, Beini, Dong, Siyi, Wei, Xuyong, Xie, Haiyang, Zheng, Shusen, Shen, Youqing, Xu, Xiao

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán